Or maybe you never had it to begin with because it was just too expensive. I have sat with more patients than I can count and they all say the same thing: losing access is traumatizing, and it permanently changes how people feel about the employers who cut them off
"Individuals with type 1 can work with their medical teams to determine whether GLP-1 receptor agonists may be beneficial for obesity treatment or glycemic management," Van Name said
Plans may differentiate by indication: a policy might cover semaglutide for T2D with minimal restrictions, but treat a Wegovy prescription with the same molecule as off-label (for weight) and therefore require stricter criteria
Sikiric said that in 1989, they found what they were looking for: a substance that seemed to possess a wide range of healing effects to help the body return to normal after it was subjected to stress
You see profound effects in organ systems that dont themselves express GLP-1 receptors, Holst says
Tirzepatide-induced biphasic anaphylactic reaction: a case report